There are 2934 resources available
Taking toxicity into account in the curative setting
Presenter: Nathan Cherny
Session: ESMO-MCBS: What have we learnt and how can we expand?
Resources:
Slides
Webcast
Challenges in grading based on disease free survival
Presenter: André Ilbawi
Session: ESMO-MCBS: What have we learnt and how can we expand?
Resources:
Slides
Webcast
Has molecular classification changed the medical approach in endometrial cancer?
Presenter: Carien Creutzberg
Session: Treating endometrial cancer in the molecular age
Resources:
Slides
Webcast
Endometrial cancer enters the immunotherapy era
Presenter: Mansoor Raza Mirza
Session: Treating endometrial cancer in the molecular age
Resources:
Slides
Webcast
5966 - EONS - Opinions of palliative care patients and nurses regarding dignified care
Presenter: Yasemin Eskigulek
Session: EONS 12: Recent trends in palliative care
Resources:
Abstract
Slides
Webcast
2454 - EONS - Development of Core Indicators of Non-Specialist Palliative Care in Hospitals – An International Modified Delphi Study
Presenter: Mary Nevin
Session: EONS 12: Recent trends in palliative care
Resources:
Abstract
Slides
1090 - Talimogene laherparepvec (T-VEC) in combination (combo) with ipilimumab (ipi) versus ipi alone for advanced melanoma: 3-year landmark analysis of a randomized, open-label, phase 2 trial
Presenter: Jason Chesney
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
1989 - Phase II multicenter open label study of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study)
Presenter: Henrik Jespersen
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3622 - Pembrolizumab for Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC): Efficacy and Safety Results From the Phase 2 KEYNOTE-629 Study
Presenter: Jean Jacques Grob
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract
3904 - SELPAC - a 3 arm randomised Phase II study of the MEK inhibitor selumetinib alone or in combination with paclitaxel (PT) in metastatic uveal melanoma (UM)
Presenter: Paul Nathan
Session: Poster Discussion – Melanoma and other skin tumours
Resources:
Abstract